CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)
Product revenue	$ 364.4	$ 328.2	$ 1,029.2	$ 946.1
Service revenue	70.0	62.3	200.4	186.5
Other revenue	1.2	3.4	5.8	8.4
Total revenue	435.6	393.9	1,235.4	1,141.0
Cost of product revenue	196.5	172.2	561.8	504.7
Cost of service revenue	40.5	35.4	114.9	110.8
Cost of other revenue	0.6	1.1	0.9	3.4
Total cost of revenue	237.6	208.7	677.6	618.9
Gross profit	198.0	185.2	557.8	522.1
Operating expenses:
Selling, general and administrative	102.9	96.8	303.8	290.4
Research and development	40.9	37.9	119.2	110.8
Other charges, net	4.3	4.6	13.8	20.6
Total operating expenses	148.1	139.3	436.8	421.8
Operating income	49.9	45.9	121.0	100.3
Interest and other expense, net	(2.5)	(2.9)	(11.8)	(11.1)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	47.4	43.0	109.2	89.2
Income tax provision (benefit)	9.8	(4.0)	25.9	3.8
Consolidated net income	37.6	47.0	83.3	85.4
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.6	0.5	1.3	0.8
Net income attributable to Bruker Corporation	$ 37.0	$ 46.5	$ 82.0	$ 84.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.23	$ 0.29	$ 0.52	$ 0.52
Diluted (in dollars per share)	$ 0.23	$ 0.29	$ 0.51	$ 0.52
Weighted average common shares outstanding:
Basic (in shares)	157.5	160.8	158.9	161.8
Diluted (in shares)	158.7	161.5	159.9	162.7
Comprehensive income	$ 61.2	$ 60.3	$ 170.3	$ 114.3
Less: Comprehensive income attributable to noncontrolling interests	0.7	0.6	1.9	0.9
Comprehensive income attributable to Bruker Corporation	$ 60.5	$ 59.7	$ 168.4	$ 113.4
Dividend declared (in dollars per share)	$ 0.04	$ 0.04	$ 0.12	$ 0.12